Catalyst Pharma: Cocaine–Addiction Drug Candidate Didn't Meet Primary Endpoint

Catalyst Pharma: Cocaine–Addiction Drug Candidate Didn't Meet Primary Endpoint
Filed under: treatment for cocaine users
Catalyst Pharmaceutical Partners Inc. (CPRX) said its potential cocaine addiction treatment, CPP-109, didn't meet the primary endpoint of a Phase II(b) study. Shares dropped 62% to 55 cents premarket as the pharmaceutical company said CPP-109, … Read more on Wall Street Journal

Addiction–Treating Drug To Be Tested In Town
Filed under: treatment for cocaine users
Evaluator for Drug Court Jesse Gerardo Hernandez, says,"we have a high rate of alcoholism and people using cocaine and they use them together. This is a perfect opportunity to work with a population that has never really been studied." The drug court … Read more on KGNS